SARS-CoV-2 IgG/IgM Rapid Test Kit |
|||
abx294171-100g | Abbexa | 100 µg | EUR 1525 |
Human IgG antibody Laboratories manufactures the sars-cov-2 antibody test reagents distributed by Genprice. The Sars-Cov-2 Antibody Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Sars-Cov-2 products are available in stock. Specificity: Sars-Cov-2 Category: Antibody Group: Test
SARS-CoV-2 Neutralization Antibody Rapid Test Kit |
||
Abbexa | 1 ml | EUR 22500 |
SARS-CoV-2 Neutralization Antibody Rapid Test Kit |
||
Abbexa | 200 µl | EUR 6600 |
SARS-CoV-2 Antigen Rapid Test |
||
Hangzhou AllTest Biotech | 25 Tests | EUR 8.75 |
Mikrogen Diagnostik recomLine SARS-CoV-2 IgG Lateral Strip Test Kit |
||
Genovis AB | 20 Tests | EUR 880 |
CoV-2 IgG S1 |
||
ProSpec Tany | 50µg | EUR 900 |
Description: Recombinant Anti Human SARS CoV-2 IgG Spike S1 |
CoV-2 IgG ELISA |
||
BioServUK | 96 tests | EUR 758 |
Description: IgG Screening ELISA |
CoV-2 IgG+ ELISA |
||
BioServUK | 24 x 4 tests | EUR 948 |
Description: IgG+ Confirmatory ELISA |
SARS CoV-2 IgG Spike S1 (CoV-2 IgG S1) Antibody |
|||
abx137719-100tests | Abbexa | 100 tests | EUR 1237.5 |
SARS CoV-2 IgG Spike S1 (CoV-2 IgG S1) Antibody |
|||
abx137720-100tests | Abbexa | 100 tests | EUR 1237.5 |
SARS CoV-2 IgM Spike S1 (CoV-2 IgM S1) Antibody |
|||
abx137721-100tests | Abbexa | 100 tests | EUR 225 |
SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] 100 ul |
|||
BSV-COV-AB-02 | BioServUK | 100 ul | EUR 602 |
Description: SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] (Spike (S2), Monoclonal) |
OAEF00177-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody |
|||
OAEF00177-1MG | Aviva Systems Biology | 1mg | EUR 471 |
OAEF00179-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody |
|||
OAEF00179-1MG | Aviva Systems Biology | 1mg | EUR 471 |
OAEF00193-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody |
|||
OAEF00193-1MG | Aviva Systems Biology | 1mg | EUR 471 |
OAEF00194-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody |
|||
OAEF00194-1MG | Aviva Systems Biology | 1mg | EUR 471 |
OAEF00195-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody |
|||
OAEF00195-1MG | Aviva Systems Biology | 1mg | EUR 471 |
SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test |
|||
ISIN-525H | Hangzhou AllTest Biotech | 25 Tests | EUR 18.75 |
SARS Antibody (CoV) (Spike) |
|||
GWB-31A5B4 | GenWay Biotech | 0.1 mg | Ask for price |
SARS Antibody (CoV Spike) |
|||
GWB-7E7002 | GenWay Biotech | 0.1 mg | Ask for price |
SARS CoV/SARS CoV 2 Spike Human mAb |
|||
E2S209908 | EnoGene | 100ul | EUR 595 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
SARS-CoV-2 (COVID-19) NSP7 Antibody |
|||
9155-002mg | ProSci | 0.02 mg | EUR 229.7 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers. |
SARS-CoV-2 (COVID-19) NSP7 Antibody |
|||
9155-01mg | ProSci | 0.1 mg | EUR 594.26 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers. |
SARS-CoV-2 (COVID-19) NSP8 Antibody |
|||
9159-002mg | ProSci | 0.02 mg | EUR 229.7 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6). |
SARS-CoV-2 (COVID-19) NSP8 Antibody |
|||
9159-01mg | ProSci | 0.1 mg | EUR 594.26 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6). |